Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV003399804 | SCV004105462 | pathogenic | PKD1-related disorder | 2023-04-07 | criteria provided, single submitter | clinical testing | The PKD1 c.4230C>A variant is predicted to result in premature protein termination (p.Tyr1410*). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. An alternative nucleotide substitution leading to the same amino acid change c.4230C>G (p.Tyr1410*) has been reported in a patient with autosomal dominant polycystic kidney disease (Table S1, Nielsen. 2021. PubMed ID: 33639313). This variant falls within a highly paralogous region. Allele frequency data should be interpreted with caution. Nonsense variants in PKD1 are expected to be pathogenic. This variant is interpreted as pathogenic. |